衛生署 衛生防護中心 胸肺科 - 有關結核病的文獻
 
主頁 > 供醫生之資訊 > 有關結核病的文獻 > 2011年至2015年

有關結核病的文獻

(有關資料只供參考，並非表示已包含所有有關結核病的文獻)

2015

  • Chou KH, Kam KM, Ieong SK, Yip CW, Ip PK, Yew WW, Leung CC, Wong NS, Lau SM, Lee SS. Concurrent Outbreaks of Tuberculosis in a School and the Wider Community in Macau. J Pediatric Infect Dis Soc. 2015 Dec;4(4):359-62
  • Chang KC, Yew WW, Sotgiu G. Clinical research in the treatment of tuberculosis: current status and future prospects. Int J Tuberc Lung Dis. 2015 Dec;19(12):1417-27. doi: 10.5588/ijtld.15.0216
  • Chen JH, She KK, Kwong TC, Wong OY, Siu GK, Leung CC, Chang KC, Tam CM, Ho PL, Cheng VC, Yuen KY, Yam WC. Performance of the new automated Abbott RealTime MTB assay for rapid detection of Mycobacterium tuberculosis complex in respiratory specimens. Eur J Clin Microbiol Infect Dis. 2015 Sep;34(9):1827-32. doi: 10.1007/s10096-015-2419-5. Epub 2015 Jun 13
  • Leung CC, Chan CK, Chang KC, Law WS, Lee SN, Tai LB, Leung EC, Tam CM. Immigrants and tuberculosis in Hong Kong. Hong Kong Med J. 2015 Aug;21(4):318-26. doi: 10.12809/hkmj144492. Epub 2015 Jul 17
  • Ho PL, Yam WC, Leung CC, Yew WW, Mok TY, Chan KS, Tam CM. Molecular tests for rapid detection of rifampicin and isoniazid resistance in Mycobacterium tuberculosis. Hong Kong Med J. 2015 Jun;21 Suppl 4:4-7
  • Tse LA, Dai J, Chen M, Liu Y, Zhang H, Wong TW, Leung CC, Kromhout H, Meijer E, Liu S, Wang F, Yu IT, Shen H, Chen W. Prediction models and risk assessment for silicosis using a retrospective cohort study among workers exposed to silica in China. Sci Rep. 2015 Jun 19;5:11059.
  • Leung CC, Tai LB, Yip I, Tam CM. Higher mortality for weekend admissions: quality of care or selection bias? Eur Respir J. 2015 Jun;45(6):1755-6.
  • Olaru ID, von Groote-Bidlingmaier F, Heyckendorf J, Yew WW, Lange C, Chang KC. Novel drugs against tuberculosis: a clinician's perspective. Eur Respir J. 2015 Apr;45(4):1119-31.
  • Takahashi K, Porcel JM, Lee P, Leung CC. Year in review 2014: Lung cancer, pleural diseases, respiratory infections and tuberculosis, bronchoscopic intervention and imaging. Respirology. 2015 May;20(4):674-83. doi: 10.1111/resp.12502. Epub 2015 Mar 3.
  • Leung CC, Yam WC, Ho PL, Yew WW, Chan CK, Law WS, Lee SN, Chang KC, Tai LB, Tam CM. T-Spot.TB outperforms tuberculin skin test in predicting development of active tuberculosis among household contacts. Respirology. 2015 Apr;20(3):496-503. doi: 10.1111/resp.12483. Epub 2015 Feb 17.
  • Villarino ME, Scott NA, Weis SE, Weiner M, Conde MB, Jones B, Nachman S, Oliveira R, Moro RN, Shang N, Goldberg SV, Sterling TR; International Maternal Pediatric and Adolescents AIDS Clinical Trials Group; Tuberculosis Trials Consortium. Treatment for preventing tuberculosis in children and adolescents: a randomized clinical trial of a 3-month, 12-dose regimen of a combination of rifapentine and isoniazid. JAMA Pediatr. 2015 Mar;169(3):247-55. doi: 10.1001/jamapediatrics.2014.3158
  • Leung CC, Yew WW, Chan CK, Chang KC, Law WS, Lee SN, Tai LB, Leung EC, Au RK, Huang SS, Tam CM. Smoking adversely affects treatment response, outcome and relapse in tuberculosis. Eur Respir J. 2015 Mar;45(3):738-45. doi: 10.1183/09031936.00114214. Epub 2014 Oct 30.
  • You JH, Lui G, Kam KM, Lee NL. Cost-effectiveness analysis of the Xpert MTB/RIF assay for rapid diagnosis of suspected tuberculosis in an intermediate burden area. J Infect. 2015 Apr;70(4):409-14. doi: 10.1016/j.jinf.2014.12.015. Epub 2015 Jan 6.
  • Ou X, Xia H, Li Q, Pang Y, Wang S, Zhao B, Song Y, Zhou Y, Zheng Y, Zhang Z, Zhang Z, Li J, Dong H, Chi J, Zhang J, Kam KM, Huan S, Jun Y, Chin DP, Zhao Y. A feasibility study of the Xpert MTB/RIF test at the peripheral level laboratory in China. Int J Infect Dis. 2015 Feb;31:41-6. doi: 10.1016/j.ijid.2014.09.011. Epub 2014 Oct 30.
  • Yew WW, Chiang CY, Lumb R, Islam T. Are pulmonary non-tuberculous mycobacteria of concern in the Western Pacific Region? Int J Tuberc Lung Dis. 2015 May;19(5):499-500. doi: 10.5588/ijtld.15.0118.
  • Nuermberger E, Yew WW. Expanding the evidence base supporting shorter treatment durations for multidrug-resistant tuberculosis. Int J Tuberc Lung Dis. 2015 May;19(5):497-8. doi: 10.5588/ijtld.15.0110.
  • Islam T, Marais BJ, Nhung NV, Chiang CY, Yew WW, Yoshiyama T, Mira NR, van den Broek J, Lumb R, Nishikiori N, Reichman LB. Western Pacific Regional Green Light Committee: progress and way forward. Int J Infect Dis. 2015 Mar;32:161-5. doi: 10.1016/j.ijid.2015.01.001.
  • Zhang Z, Liu M, Wang Y, Pang Y, Kam KM, Zhao Y. Molecular and phenotypic characterization of multidrug-resistant Mycobacterium tuberculosis isolates resistant to kanamycin, amikacin, and capreomycin in China. Eur J Clin Microbiol Infect Dis. 2014 Nov;33(11):1959-66. doi: 10.1007/s10096-014-2144-5. Epub 2014 Jun 7.
  • Olaru ID, von Groote-Bidlingmaier F, Heyckendorf J, Yew WW, Lange C, Chang KC. Novel drugs against tuberculosis: a clinician's perspective. Eur Respir J. 2015 Apr;45(4):1119-31. doi: 10.1183/09031936.00162314. Epub 2014 Nov 27. Review.

返回頁首

2014

  • Tse LA, Yu IT, Qiu H, Leung CC. Joint effects of smoking and silicosis on diseases to the lungs. PLoS One. 2014 Aug 8;9(8):e104494. doi: 10.1371/journal.pone.0104494. eCollection 2014.
  • Bastos ML, Hussain H, Weyer K, Garcia-Garcia L, Leimane V, Leung CC, Narita M, Penã JM, Ponce-de-Leon A, Seung KJ, Shean K, Sifuentes-Osornio J, Van der Walt M, Van der Werf TS, Yew WW, Menzies D; Collaborative Group for Meta-analysis of Individual Patient Data in MDR-TB. Treatment outcomes of patients with multidrug-resistant and extensively drug-resistant tuberculosis according to drug susceptibility testing to first- and second-line drugs: an individual patient data meta-analysis. Clin Infect Dis. 2014 Nov 15;59(10):1364-74. doi: 10.1093/cid/ciu619. Epub 2014 Aug 5
  • Leung CC, Porcel JM, Takahashi K, Restrepo MI, Lee P, Wainwright C. Year in review 2013: Lung cancer, respiratory infections, tuberculosis, cystic fibrosis, pleural diseases, bronchoscopic intervention and imaging. Respirology. 2014 Apr;19(3):448-60. doi: 10.1111/resp.12250. Epub 2014 Feb 21. Review.
  • de Beer JL, Ködmön C, van Ingen J, Supply P, van Soolingen D; Global Network for Molecular Surveillance of Tuberculosis 2010. Second worldwide proficiency study on variable number of tandem repeats typing of Mycobacterium tuberculosis complex. Int J Tuberc Lung Dis. 2014 May;18(5):594-600. doi: 10.5588/ijtld.13.0531.
  • Ou X, Li Q, Xia H, Pang Y, Wang S, Zhao B, Song Y, Zhou Y, Zheng Y, Zhang Z, Zhang Z, Li J, Dong H, Zhang J, Kam KM, Chi J, Huan S, Chin DP, Zhao Y. Diagnostic accuracy of the PURE-LAMP test for pulmonary tuberculosis at the county-level laboratory in China. PLoS One. 2014 May 1;9(5):e94544. doi: 10.1371/journal.pone.0094544. eCollection 2014
  • Zhang Z, Wang Y, Pang Y, Kam KM. Ethambutol resistance as determined by broth dilution method correlates better than sequencing results with embB mutations in multidrug-resistant Mycobacterium tuberculosis isolates. J Clin Microbiol. 2014 Feb;52(2):638-41. doi: 10.1128/JCM.02713-13. Epub 2013 Nov 27.
  • Kam KM. Microscopic observation drug susceptibility (MODS): where are we going? Int J Tuberc Lung Dis. 2014 Feb;18(2):127. doi: 10.5588/ijtld.13.0777.
  • Lange C, Abubakar I, Alffenaar JW, Bothamley G, Caminero JA, Carvalho AC, Chang KC, Codecasa L, Correia A, Crudu V, Davies P, Dedicoat M, Drobniewski F, Duarte R, Ehlers C, Erkens C, Goletti D, Günther G, Ibraim E, Kampmann B, Kuksa L, de Lange W, van Leth F, van Lunzen J, Matteelli A, Menzies D, Monedero I, Richter E, Rüsch-Gerdes S, Sandgren A, Scardigli A, Skrahina A, Tortoli E, Volchenkov G, Wagner D, van der Werf MJ, Williams B, Yew WW, Zellweger JP, Cirillo DM; TBNET. Management of patients with multidrug-resistant/extensively drug-resistant tuberculosis in Europe: a TBNET consensus statement. Eur Respir J. 2014 Jul;44(1):23-63. doi: 10.1183/09031936.00188313. Epub 2014 Mar 23.

返回頁首

2013

  • Jiang GL, Chen X, Song Y, Zhao Y, Huang H, Kam KM. First proficiency testing of second-line anti-tuberculosis drug susceptibility testing in 12 provinces of China. Int J Tuberc Lung Dis. 2013 Nov;17(11):1491-4. doi: 10.5588/ijtld.13.0275.
  • Pang Y, Li Q, Ou X, Sohn H, Zhang Z, Li J, Xia H, Kam KM, O'Brien RJ, Chi J, Huan S, Chin DP, Zhao YL. Cost-effectiveness comparison of Genechip and conventional drug susceptibility test for detecting multidrug-resistant tuberculosis in China. PLoS One. 2013 Jul 23;8(7):e69267. doi: 10.1371/journal.pone.0069267. Print 2013
  • Yu WC, Fu SN, Tai EL, Yeung YC, Kwong KC, Chang Y, Tam CM, Yiu YK. Spirometry is underused in the diagnosis and monitoring of patients with chronic obstructive pulmonary disease (COPD). Int J Chron Obstruct Pulmon Dis. 2013;8:389-95. doi: 10.2147/COPD.S48659. Epub 2013 Aug 26.
  • Leung CC, Hui DS, Chan PK. Controlling novel avian influenza A (H7N9) at animal sources. BMJ. 2013 Sep 18;347:f5565. doi: 10.1136/bmj.f5565.
  • Chan CK, Wong KH, Leung CC, Tam CM, Chan KC, Pang KW, Chan WK, Mak IK. Treatment outcomes after early initiation of antiretroviral therapy for human immunodeficiency virus-associated tuberculosis. Hong Kong Med J. 2013 Dec;19(6):474-83. doi: 10.12809/hkmj133937. Epub 2013 Aug 8.
  • Leung CC, Lange C, Zhang Y. Tuberculosis: current state of knowledge: an epilogue. Respirology. 2013 Oct;18(7):1047-55. doi: 10.1111/resp.12156. Review.
  • Lee SS, Meintjes G, Kamarulzaman A, Leung CC. Management of tuberculosis and latent tuberculosis infection in human immunodeficiency virus-infected persons. Respirology. 2013 Aug;18(6):912-22. doi: 10.1111/resp.12120. Review.
  • Lee SS, Wong NS, Leung CC. Exposure to avian influenza H7N9 in farms and wet markets. Lancet. 2013 May 25;381(9880):1815. doi: 10.1016/S0140-6736(13)60949-6. Epub 2013 May 10.
  • Falzon D, Gandhi N, Migliori GB, Sotgiu G, Cox HS, Holtz TH, Hollm-Delgado MG, Keshavjee S, DeRiemer K, Centis R, D'Ambrosio L, Lange CG, Bauer M, Menzies D; Collaborative Group for Meta-Analysis of Individual Patient Data in MDR-TB. Resistance to fluoroquinolones and second-line injectable drugs: impact on multidrug-resistant TB outcomes. Eur Respir J. 2013 Jul;42(1):156-68. doi: 10.1183/09031936.00134712. Epub 2012 Oct 25.
  • Migliori GB, Sotgiu G, Gandhi NR, Falzon D, DeRiemer K, Centis R, Hollm-Delgado MG, Palmero D, Pérez-Guzmán C, Vargas MH, D'Ambrosio L, Spanevello A, Bauer M, Chan ED, Schaaf HS, Keshavjee S, Holtz TH, Menzies D; Collaborative Group for Meta-Analysis of Individual Patient Data in MDR-TB. Drug resistance beyond extensively drug-resistant tuberculosis: individual patient data meta-analysis. Eur Respir J. 2013 Jul;42(1):169-79. doi: 10.1183/09031936.00136312. Epub 2012 Oct 11.
  • Koh WJ, Stout JE, Yew WW. Advances in the management of pulmonary disease due to Mycobacterium abscessus complex. Int J Tuberc Lung Dis. 2014 Oct;18(10):1141-8. doi: 10.5588/ijtld.14.0134.
  • Yew WW, Lange C. Linezolid in the treatment of drug-resistant tuberculosis: the way forward? Int J Tuberc Lung Dis. 2014 Jun;18(6):631-2. doi: 10.5588/ijtld.14.0191.
  • Yew WW, Lange C. Fluoroquinolone resistance in Mycobacterium tuberculosis. What have we learnt? Int J Tuberc Lung Dis. 2014 Jan;18(1):1-2. doi: 10.5588/ijtld.13.0739.
  • Chang KC, Dheda K. Rationalizing Use of Fluoroquinolones and Pyrazinamide in the Battle against Multidrug-Resistant Tuberculosis. Am J Respir Crit Care Med. 2013 Jul 1;188(1):10-1. doi: 10.1164/rccm.201304-0697ED. PubMed PMID: 23815718.
  • Hales CM, Heilig CM, Chaisson R, Leung CC, Chang KC, Goldberg SV, Gordin F, Johnson JL, Muzanyi G, Saukkonen J, Vernon A, Villarino ME, Burman WJ. The association between symptoms and microbiologically defined response to tuberculosis treatment. Ann Am Thorac Soc. 2013 Feb;10(1):18-25. doi: 10.1513/AnnalsATS.201207-038OC. PubMed PMID: 23509328.
  • Chang KC, Yew WW, Tam CM, Leung CC. WHO Group 5 drugs and difficult multidrug-resistant tuberculosis: a systematic review with cohort analysis andmeta-analysis. Antimicrob Agents Chemother. 2013 Sep;57(9):4097-104. doi: 10.1128/AAC.00120-13. Epub 2013 Jun 17. Review.
  • Chang KC, Yew WW, Cheung SW, Leung CC, Tam CM, Chau CH, Wen PK, Chan RC. Can intermittent dosing optimize prolonged linezolid treatment of difficult multidrug-resistant tuberculosis? Antimicrob Agents Chemother. 2013 Jul;57(7):3445-9. doi: 10.1128/AAC.00388-13. Epub 2013 May 6. PubMed PMID: 23650165; PubMed Central PMCID: PMC3697330.
  • Leung EC, Leung CC, Kam KM, Yew WW, Chang KC, Leung WM, Tam CM. Transmission of multidrug-resistant and extensively drug-resistant tuberculosis in ametropolitan city. Eur Respir J. 2013 Apr;41(4):901-8. doi:10.1183/09031936.00071212. Epub 2012 Aug 9. PubMed PMID: 22878878
  • Wang X, Tang NL, Leung CC, Kam KM, Yew WW, Tam CM, Chan CY. Association of polymorphisms in the Chr18q11.2 locus with tuberculosis in Chinese population.Hum Genet. 2013 Jun;132(6):691-5. doi: 10.1007/s00439-013-1282-7. Epub 2013 Mar 3. PubMed PMID: 23456169.
  • Xia H, Song YY, Zhao B, Kam KM, O'Brien RJ, Zhang ZY, Sohn H, Wang W, Zhao YL. Multicentre evaluation of Ziehl-Neelsen and light-emitting diode fluorescence microscopy in China. Int J Tuberc Lung Dis. 2013 Jan;17(1):107-12. doi: 10.5588/ijtld.12.0184. PubMed PMID: 23232010.
  • Leung CC. 2012: The year in review. Part II: Tuberculosis and lung disease. Int J Tuberc Lung Dis. 2013 Sep;17(9):1151-9. doi: 10.5588/ijtld.13.0385. Epub 2013 Jul 3. Review.
  • Yip PC, Kam KM, Lam ET, Chan RC, Yew WW. In vitro activities of PNU-100480 and linezolid against drug-susceptible and drug-resistant Mycobacterium tuberculosis isolates. Int J Antimicrob Agents. 2013 Jul;42(1):96-7. doi:10.1016/j.ijantimicag.2013.03.002. Epub 2013 May 15. PubMed PMID: 23684005
  • Leung KL, Yip CW, Tang HS, Lai YW, Lam TK, Kam KM. A pilot external quality assurance programme for line-probe assay detection of anti-tuberculosis drug resistance. Int J Tuberc Lung Dis. 2013 Feb;17(2):262-6. doi:10.5588/ijtld.12.0533. Epub 2012 Dec 14. PubMed PMID: 23244351.
  • Leung CC, Hui L, Lee RS, Lam TH, Yew WW, Hui DS, Chan RC, Mok TY, Law WS, Chang KC, Leung EC, Tam CM. Tuberculosis is associated with increased lung cancer mortality. Int J Tuberc Lung Dis. 2013 May;17(5):687-92. doi: 10.5588/ijtld.12.0816. PubMed PMID: 23575337.
  • Chang KC, Sterling TR, Yew WW. Are we ready to shorten the treatment duration for non-cavitary pulmonary tuberculosis? Int J Tuberc Lung Dis. 2013 Jun;17(6):712. doi: 10.5588/ijtld.13.0120. PubMed PMID: 23676152.
  • Yew WW, Nuermberger E. High-dose fluoroquinolones in short-course regimens for treatment of MDR-TB: the way forward? [Editorial]. Int J Tuberc Lung Dis. 2013 Jul;17(7):853-4. doi: 10.5588/ijtld.13.0301. PubMed PMID: 23743304.
  • Pang Y, Xia H, Zhang Z, Li J, Dong Y, Li Q, Ou X, Song Y, Wang Y, O'Brien R, Kam KM, Chi J, Huan S, Chin DP, Zhao Y. Multicenter evaluation of genechip for detection of multidrug-resistant Mycobacterium tuberculosis. J Clin Microbiol. 2013 Jun;51(6):1707-13. doi: 10.1128/JCM.03436-12. Epub 2013 Mar 20. PubMed PMID: 23515537; PubMed Central PMCID: PMC3716084.
  • Chang KC, Leung CC, Daley CL. Linezolid for multidrug-resistant tuberculosis- authors' reply. Lancet Infect Dis. 2013 Jan;13(1):16-7. doi: 10.1016/S1473-3099(12)70272-4. PubMed PMID: 23257227.
  • Cheung MK, Lam WY, Fung WY, Law PT, Au CH, Nong W, Kam KM, Kwan HS, Tsui SK. Sputum microbiota in tuberculosis as revealed by 16S rRNA pyrosequencing. PLoS One. 2013;8(1):e54574. doi: 10.1371/journal.pone.0054574. Epub 2013 Jan 24. PubMed PMID: 23365674; PubMed Central PMCID: PMC3554703.
  • Chang KC, Yew WW. Management of difficult multidrug-resistant tuberculosis and extensively drug-resistant tuberculosis: update 2012. Respirology. 2013 Jan;18(1):8-21. doi: 10.1111/j.1440-1843.2012.02257.x. Review. PubMed PMID: 22943408.
  • Porcel JM, Leung CC, Restrepo MI, Takahashi K, Lee P. Year in review 2012: lung cancer, respiratory infections, tuberculosis, pleural diseases, bronchoscopic intervention and imaging. Respirology. 2013 Apr;18(3):573-83. doi: 10.1111/resp.12048. PubMed PMID: 23317457; PubMed Central PMCID: PMC3606639.
  • Lee SS, Meintjes G, Kamarulzaman A, Leung CC. Management of tuberculosis and latent tuberculosis infection in HIV-infected persons. Respirology. 2013 May 20. doi: 10.1111/resp.12120. [Epub ahead of print] PubMed PMID: 23682586.
  • Leung CC, Lange C, Zhang Y. Tuberculosis: Current state of knowledge: An Epilogue. Respirology. 2013 Jul 10. doi: 10.1111/resp.12156. [Epub ahead of print] PubMed PMID: 23837600.

返回頁首

2012

  • Chang KC, Leung CC. Lung cancer is more common in early GOLD stages of COPD: a spurious association? Am J Respir Crit Care Med. 2012 May 15;185(10):1128; author reply 1128-9.
  • Leung CC, Yu IT, Chen W. Silicosis. Lancet. 2012 May 26;379(9830):2008-18. doi: 10.1016/S0140-6736(12)60235-9. Epub 2012 Apr 24. Review.
  • Chang KC, Leung CC, Yew WW, Leung EC, Leung WM, Tam CM, Zhang Y. Pyrazinamide may improve fluoroquinolone-based treatment of multidrug-resistant tuberculosis. Antimicrob Agents Chemother. 2012 Nov;56(11):5465-75. doi: 10.1128/AAC.01300-12. Epub 2012 Aug 6. PubMed PMID: 22869570; PubMed Central PMCID: PMC3486566.
  • Shea YF, Chan JFW, Kwok WC, Hwang YY, Chan TC, Ni MYX, Li IWS, Chiu PKC, Luk JKH, Chu LW. Haemophagocytic lymphohistiocytosis: an uncommon clinical presentation of tuberculosis. Hong Kong Med J 2012; 18: 517-25.
  • Leung CC, Lam TH, Yew WW, Law WS, Tam CM, Chang KC, McGhee S, Tam SY, Chan KF.Obstructive lung disease does not increase lung cancer mortality among female never-smokers in Hong Kong. Int J Tuberc Lung Dis. 2012 Apr;16(4):546-52. doi: 10.5588/ijtld.11.0573. PubMed PMID: 22325953.
  • Chang KC, Nuermberger EL. 2011: the year in review. part I: tuberculosis. Int J Tuberc Lung Dis. 2012 Jun;16(6):740-8. doi: 10.5588/ijtld.12.0139. Review PubMed PMID: 22613685.
  • Leung CC, Caminero JA. Empirical use of fluoroquinolones for chest infections may mask tuberculosis and jeopardise chances of survival. Int J Tuberc Lung Dis. 2012 Sep;16(9):1137. doi: 10.5588/ijtld.12.0518. PubMed PMID: 22871321.
  • Leung CC. Tests for prediction of active tuberculosis. Lancet Infect Dis.2012 Jan;12(1):6-8. doi: 10.1016/S1473-3099(11)70215-8. Epub 2011 Aug 16. PubMed PMID: 21846593.
  • Chang KC, Leung CC, Daley CL. Linezolid for multidrug-resistant tuberculosis.Lancet Infect Dis. 2012 Jul;12(7):502-3. doi: 10.1016/S1473-3099(12)70137-8.PubMed PMID: 22742623.
  • Leung CC, Yew WW, Au KF, Tam CM, Chang KC, Mak KY, Tam SY, Chan KF, Fong KL, Tam SW. A strong tuberculin reaction in primary school children predicts tuberculosis in adolescence. Pediatr Infect Dis J. 2012 Feb;31(2):150-3. doi:10.1097/INF.0b013e318236ae2b. PubMed PMID: 21983215.
  • Ahuja SD, Ashkin D, Avendano M, Banerjee R, Bauer M, Bayona JN, Becerra MC, Benedetti A, Burgos M, Centis R, Chan ED, Chiang CY, Cox H, D'Ambrosio L, DeRiemer K, Dung NH, Enarson D, Falzon D, Flanagan K, Flood J, Garcia-Garcia ML, Gandhi N, Granich RM, Hollm-Delgado MG, Holtz TH, Iseman MD, Jarlsberg LG, Keshavjee S, Kim HR, Koh WJ, Lancaster J, Lange C, de Lange WC, Leimane V, Leung CC, Li J, Menzies D, Migliori GB, Mishustin SP, Mitnick CD, Narita M, O'Riordan P, Pai M, Palmero D, Park SK, Pasvol G, Peña J, Pérez-Guzmán C, Quelapio MI, Ponce-de-Leon A, Riekstina V, Robert J, Royce S, Schaaf HS, Seung KJ, Shah L, Shim TS, Shin SS, Shiraishi Y, Sifuentes-Osornio J, Sotgiu G, Strand MJ, Tabarsi P, Tupasi TE, van Altena R, Van der Walt M, Van der Werf TS, Vargas MH, Viiklepp P, Westenhouse J, Yew WW, Yim JJ; Collaborative Group for Meta-Analysis of Individual Patient Data in MDR-TB. Multidrug resistant pulmonary tuberculosis treatment regimens and patient outcomes: an individual patient data meta-analysis of 9,153 patients. PLoS Med. 2012;9(8):e1001300. Epub 2012 Aug 28. PubMed PMID: 22952439; PubMed Central PMCID: PMC3429397.
  • Porcel JM, Leung CC, Restrepo MI, Lee P. Year in review 2011: respiratory infections, tuberculosis, pleural diseases, bronchoscopic intervention and imaging. Respirology. 2012 Apr;17(3):573-82. doi:10.1111/j.1440-1843.2012.02128.x. PubMed PMID: 22248294.

返回頁首

2011

  • Leung CC, Lam TH, Yew WW, Chan WM, Law WS, Tam CM. Lower lung cancer mortality in obesity. Am J Epidemiol 2011 Feb; 40(1): 174-82
  • Chang KC, Leung CC, Tam CM, Yew WW. Streptomycin susceptibility and MDR-TB: can we refine the definition of XDR-TB? Am J Respir Crit Care Med 2011 Jan 15: 183(2): 278
  • Lau RW, Ho PL, Kao RY, Yew WW, Lau TC, Cheng VC, Yuen KY, Tsui SK, Chen X, Yam WC. Molecular characterization of fluoroquinolone resistance in mycobacterium tuberculosis: functional analysis of gyrA mutant at position 74. Antimicrob Agents Chemother 2011 Feb; 55(2): 608-14.
  • Chang KC, Yew WW, Zhang Y. Pyrazinamide susceptibility testing in Mycobacterium tuberculosis: a systematic review with meta-analyses. Antimicrob Agents Chemother. 2011 Oct;55(10):4499-505. doi: 10.1128/AAC.00630-11. Epub 2011 Jul 18. Review. PubMed PMID: 21768515; PubMed Central PMCID: PMC3186960.
  • Siu GK, Tam YH, Ho PL, Lee AS, Que TL, Tse CW, Yip KT, Lam JT, Cheng VC, Yuen KY, Yam WC. Direct detection of isoniazid-resistant Mycobacterium tuberculosis in respiratory specimens by multiplex allele-specific polymerase chain reaction. Diagn Microbiol Infect Dis 2011; 69(1):51-8.
  • Yew WW, Lange C, Leung CC. Treatment of tuberculosis: update 2010. Eur Respir J. 2011 Feb: 37(2): 441-62. [Epub 2010 Sept 16]
  • Leung CC, Rieder HL, Lange C, Yew WW. Treatment of latent infection with M. tuberculosis: update 2010. Eur Respir J. 2011 Mar; 37(3): 690-711. [Epub2010 Aug 6]
  • Leung EC, Yew WW, Leung CC, Leung WM, Tam CM. Shorter treatment duration for selected patients with multidrug-resistant tuberculosis. Eur Respir J. 2011Jul;38(1):227-30. doi: 10.1183/09031936.00186310. PubMed PMID: 21719503.
  • Yew WW, Cynamon M, Zhang Y. Emerging drugs for the treatment of tuberculosis. Expert Opin Emerg Drugs 2011 Mar; 16(1):1-21.
  • Chan WM, et al. Management of Bacillus Calmette-Guerin lymphadenitis. Hong Kong J Paed 2011;16(2):85-94.
  • Yu WC, Tai EL, Fu SN, Kwong KC, Yeung YC, Chang Y, Yiu YK, Tam CM. Treatment of patients with chronic obstructive pulmonary disease as practised in a defined Hong Kong community: a cross-sectional pilot survey. Hong Kong Med J. 2011 Aug;17(4):306-14
  • Tang NL, Chan CY, Leung CC, Tam CM, Blackwell J. Tuberculosis susceptibility genes in the chemokine cluster region of chromosome 17 in Hong Kong Chinese. Hong Kong Med J. 2011 Dec;17 Suppl 6:22-5. PubMed PMID: 22147355.
  • Leung CC, Lam TH, Yew WW, Chan WM, Law WS, Tam CM. Lower lung cancer mortality in obesity. Int J Epidemiol. 2011 Feb;40(1):174-82. doi: 10.1093/ije/dyq134. Epub 2010 Aug 12. PubMed PMID: 20709687
  • Zumla A, Yew WW. New tools for achieving tuberculosis control: progress and reflexion. Int J Terberc Lung Dis. 2011 Mar; 15(3): 285-6.
  • Leung CC, Yew WW, Grosset J. Harnessing the full sterilizing activity of rifamycins. Int J Terberc Lung Dis. 2011 Apr; 15(4): 429-30.
  • Lo AI, Huang Y, Lam SY, Cheung AH, Au R, Leung CC, Lam WK, Ip MS, Chan-Yeung M, Lam B. Early detection of central airway lung cancer in smokers with silicosis. Int J Tuberc Lung Dis 2011 Apr;15(4):523-7.
  • Rieder HL, Anderson C, Dara M, Hauer B, Helbling P, Kam KM, Zwahlen M.Methodological issues in quantifying the magnitude of the tuberculosis problem in a prison population. Int J Tuberc Lung Dis. 2011 May;15(5):662-7. doi:10.5588/ijtld.10.0433. PubMed PMID: 21756519.
  • Chang KC, Yew WW. What is the role of autofluorescence bronchoscopy in screening lung cancer among silicotic subjects? Int J Tuberc Lung Dis. 2011 Sep;15(9):1277-8; author reply 1278.
  • Leung CC. Reexamining the role of radiography in tuberculosis case finding. Int J Tuberc Lung Dis. 2011 Oct;15(10):1279. doi: 10.5588/ijtld.11.0425. PubMed PMID: 22283882.
  • Siu GK, Zhang Y, Lau TC, Lau RW, Ho PL, Yew WW, Tsui SK, Cheng VC, Yuen KY, Yam WC. Mutations outside the rifampicin resistance-determining region associated with rifampicin resistance in Mycobacterium tuberculosis. J Antimicrob Chemother. 2011 Apr; 66(4): 730-3. [Epub 2011Jan 17].
  • Yew WW. Management of multidrug-resistant tuberculosis and extensive drug-resistant tuberculosis: current status and future prospects. Kekkaku. 2011 Jan; 86(1): 9-16.
  • Leung CC, Feller-Kopman D, Niederman MS, Spiro SG. Year in review 2010: Tuberculosis, pleural diseases, respiratory infections. Respirology. 2011 April;16(3):564-73
  • Chang KC, Leung CC, Grosset J, Yew WW. Treatment of tuberculosis and optimal dosing schedules. Thorax. 2011 Nov;66(11):997-1007

返回頁首